MKA
AMGN icon

M. Kulyk & Associates’s Amgen AMGN Stock Holding History

M. Kulyk & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Sell
741
-405
-35% -$139K 0.04% 103
2026
Q1 		$403K Sell
1,146
-328
-22% -$117K 0.08% 82
2025
Q4 		$483K Sell
1,474
-62
-4% -$19.7K 0.09% 68
2025
Q3 		$434K Sell
1,536
-21,991
-93% -$6.38M 0.09% 68
2025
Q2 		$6.57M Buy
23,527
+1,205
+5% +$341K 1.43% 25
2025
Q1 		$6.95M Sell
22,322
-94
-0.4% -$27.8K 1.59% 21
2024
Q4 		$5.84M Sell
22,416
-144
-0.6% -$42.7K 1.26% 30
2024
Q3 		$7.27M Sell
22,560
-235
-1% -$76.9K 1.46% 26
2024
Q2 		$7.12M Buy
22,795
+569
+3% +$167K 1.65% 21
2024
Q1 		$6.32M Sell
22,226
-168
-0.8% -$49.2K 1.47% 24
2023
Q4 		$6.45M Sell
22,394
-944
-4% -$257K 1.5% 26
2023
Q3 		$6.27M Buy
23,338
+545
+2% +$136K 1.74% 15
2023
Q2 		$5.06M Buy
22,793
+573
+3% +$133K 1.41% 28
2023
Q1 		$5.37M Buy
22,220
+733
+3% +$180K 1.63% 24
2022
Q4 		$5.64M Buy
21,487
+63
+0.3% +$16.9K 1.88% 15
2022
Q3 		$4.83M Buy
21,424
+401
+2% +$97.2K 1.68% 17
2022
Q2 		$5.12M Buy
21,023
+358
+2% +$87.7K 1.59% 19
2022
Q1 		$5M Sell
20,665
-5,203
-20% -$1.2M 1.36% 27
2021
Q4 		$5.82M Buy
25,868
+1,639
+7% +$346K 1.51% 26
2021
Q3 		$5.15M Buy
24,229
+1,583
+7% +$364K 1.65% 21
2021
Q2 		$5.52M Buy
22,646
+1,996
+10% +$491K 1.99% 15
2021
Q1 		$5.14M Buy
20,650
+6,296
+44% +$1.5M 1.92% 13
2020
Q4 		$3.3M Buy
+14,354
New +$3.31M 1.83% 22

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

M. Kulyk & Associates's AMGN Position: Q2 2026 in Review

M. Kulyk & Associates reduced its Amgen (AMGN) stake by 35% in Q2 2026, selling an estimated $139K and leaving 741 shares worth $268K. The position accounts for 0.04% of the portfolio, ranked #103.

M. Kulyk & Associates first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.27M in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • M. Kulyk & Associates held 741 shares of Amgen worth $268K as of Q2 2026.
  • M. Kulyk & Associates sold 405 Amgen shares in Q2 2026, an estimated $139K.
  • Amgen made up 0.04% of M. Kulyk & Associates's portfolio in Q2 2026, its #103 holding.
  • M. Kulyk & Associates first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • M. Kulyk & Associates's Amgen position peaked at $7.27M in Q3 2024.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on M. Kulyk & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.